Loading...
Creatine as a Therapeutic Target in Alzheimer's Disease
Taylor, Matthew K. Sullivan, Debra K. Keller, Jessica E. Herda, Trent J. Carbuhn, Aaron F. Morris, Jill K. Smith, Aaron N.
Taylor, Matthew K.
Sullivan, Debra K.
Keller, Jessica E.
Herda, Trent J.
Carbuhn, Aaron F.
Morris, Jill K.
Smith, Aaron N.
Abstract
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, affecting approximately 6.5 million older adults in the United States. Development of AD treatment has primarily centered on developing pharmaceuticals that target amyloid-β (Aβ) plaques in the brain, a hallmark pathological biomarker that precedes symptomatic AD. Though recent clinical trials of novel drugs that target Aβ have demonstrated promising preliminary data, these pharmaceuticals have a poor history of developing into AD treatments, leading to hypotheses that other therapeutic targets may be more suitable for AD prevention and treatment. Impaired brain energy metabolism is another pathological hallmark that precedes the onset of AD that may provide a target for intervention. The brain creatine (Cr) system plays a crucial role in maintaining bioenergetic flux and is disrupted in AD. Recent studies using AD mouse models have shown that supplementing with Cr improves brain bioenergetics, as well as AD biomarkers and cognition. Despite these promising findings, no human trials have investigated the potential benefits of Cr supplementation in AD. This narrative review discusses the link between Cr and AD and the potential for Cr supplementation as a treatment for AD.
Description
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.
Date
2023-11-30
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Files
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Aaron N. Smith, Jill K. Morris, Aaron F. Carbuhn, Trent J. Herda, Jessica E. Keller, Debra K. Sullivan, Matthew K. Taylor, Creatine as a Therapeutic Target in Alzheimer's Disease, Current Developments in Nutrition, Volume 7, Issue 11, 2023, 102011, ISSN 2475-2991, https://doi.org/10.1016/j.cdnut.2023.102011.